| Autor: |
Salili AR; 1 Medizinische Universitätsklinik, Kantonsspital Aarau.; 2 Department Klinische Pharmakologie und Toxikologie, Universität und Universitätsspital Basel., Hammann F; 2 Department Klinische Pharmakologie und Toxikologie, Universität und Universitätsspital Basel., Taegtmeyer AB; 2 Department Klinische Pharmakologie und Toxikologie, Universität und Universitätsspital Basel. |
| Jazyk: |
němčina |
| Zdroj: |
Therapeutische Umschau. Revue therapeutique [Ther Umsch] 2015 Dec; Vol. 72 (11-12), pp. 693-700. |
| DOI: |
10.1024/0040-5930/a000739 |
| Abstrakt: |
Adverse drug events pose a great risk to patients, are an everyday clinical problem and can have potential/ega/ consequences. Computerized physician order entry or computerized provider order entry (CPOE} in combination with clinical decision support systems {CDSS) are popular and aim to reduce prescribing errors as well as identifying potentially harmful drug drug interactions. The quantifiable benejit these systems bring to patients, has however, yet to be definitively proven. This article focusses on the current standpoint of CPOE-/CDSS, their risks and benefits, the potential for improvement and their perspectives for the future. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
